Impact of Paris Court Ruling on Angelalign Customers
On October 19, 2026,
Angelalign Technology Inc. (6699.HK), a pioneer in orthodontic technology, announced that a recent ruling from the Paris local division of the Unified Patent Court regarding their withdrawn technology,
Torque Ridges, will have negligible consequences for their customers. Instead of the outdated Torque Ridges, Angelalign has already implemented an upgraded solution known as
Pressure Points in their European markets. This transition underscores Angelalign's dedication to innovation and addressing the clinical needs of orthodontists worldwide.
Swift Transition to New Technology
The Pressure Points technology was introduced in Europe in September of the same year, offering superior control over tooth inclination compared to its predecessor. This strategic update serves as a testament to Angelalign's commitment to continuously advancing orthodontic solutions. The company reassured its clientele, stating that the ruling will not hinder their access to cutting-edge orthodontic treatments. Angelalign successfully replaced the Torque Ridges with the Pressure Points technology, fully supporting orthodontists in providing high-quality services to their patients.
Ruling Details and Company Position
The court decided that the Torque Ridges solution infringed upon a patent held by
Align Technology Inc. (ALGN), pertaining to the movement of patients' teeth as per orthodontic treatment plans. In response to the ruling, Angelalign expressed its disagreement and commitment to analyzing the court’s decision thoroughly, considering possible courses of action while planning compliance with the ruling, including the return of impacted products. However, as this technology has already been phased out in Europe, orthodontists using Angelalign's services can continue to treat their patients with Pressure Points, receiving ongoing clinical and technical support from the company.
Commitment to Orthodontic Care
Xavier Cherbavaz, CEO and VP of Angelalign for Europe, Africa, and the Middle East, emphasized the company’s priority: ensuring orthodontists deliver top-notch care to their patients. He noted that the innovative Pressure Points technology enables controlled force application and provides reliable contact with teeth during treatment. The focus remains on delivering clinical solutions that enhance both the quality and effectiveness of orthodontic procedures.
Richard Hirschland, Chief Commercial Officer at Angelalign, added that the company places significant emphasis on protecting intellectual property rights and strives not to infringe on crucial patents. Angelalign is performing a meticulous review of the court’s justification and will evaluate all available options for further action. Despite the legal dispute, the company is determined to continue its innovative efforts, enhancing its products for the betterment of collaborating orthodontists and their patients.
Looking Ahead
Angelalign's shift to Pressure Points signifies not only their acute understanding of the current market and technological landscape but also their proactive nature in predicting challenges and developing solutions that maintain high customer service standards. The company confirms its dedication to evolving innovative solutions that orthodontists can trust in the long term. Furthermore, Angelalign hopes to continue fostering reliable relationships with practitioners and ensuring patient satisfaction.
For more details regarding Angelalign and its technologies, visit
angelaligner.com/eu and
angelaligner.com. Established in 2003 and publicly listed since 2021, Angelalign operates in over 60 countries, offering expert orthodontic aligner solutions. With more than 2 million treatment cases to date and a market capitalization of approximately $2 billion, Angelalign is well-positioned within the orthodontic sector, continuously investing in innovation to enhance outcomes for both practitioners and patients.